Altre lingue BioPharma Credit PLC

Azioni

BPCP

GB00BDGKMY29

Mercato chiuso - London S.E. Altri mercati azionari 17:35:01 05/07/2024			Variaz. 5gg	Var. 1 gen.
0,854 ^USD	0,00%		+1,67%	+1,67%

01/07	BioPharma Credit fornirà ulteriori finanziamenti a LumiraDx nell'ambito dell'accordo con Roche	MT
20/06	BioPharma Credit PLC dichiara un dividendo intermedio in relazione al periodo finanziario conclusosi il 30 giugno 2024, pagabile il 31 luglio 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

BioPharma Credit to Provide Additional Funding to LumiraDx Amid Roche Deal	01/07
BioPharma Credit PLC Declares Interim Dividend in Respect of the Financial Period Ending 30 June 2024, Payable on 31 July 2024	20/06
BioPharma Credit : Resolutions passed at AGM	13/06
BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg	02/05
BioPharma Credit agrees USD400 million loan for oncology firm Novacure	02/05
BioPharma Credit, Unit to Loan up to $100 Million Each to US-based Tarsus Pharmaceuticals	24/04
BioPharma Credit to loan USD100 million to Tarsus Pharmaceuticals	24/04
BioPharma Credit PLC Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
BioPharma Credit net asset value ticks up but total payout lower	27/03
BioPharma Credit Board, Investment Manager Propose Changes to Discount Control Mechanism	27/03
BioPharma Credit Logs Lower FY23 Net Income Return on Ordinary Activities	27/03
Tranche Update on BioPharma Credit PLC's Equity Buyback Plan announced on May 31, 2023.	27/03
Biopharma Credit plc Declares Interim Dividend in Respect of the Financial Period Ending 31 March 2024, Payable on 30 April 2024	21/03
BioPharma Credit gets USD50.6 million from Abbvie's ImmunoGen purchase	13/02
Biopharma Credit Secures $51 Million Loan Repayment from US Biotech ImmunoGen	13/02
BioPharma Credit PLC Declares Interim Special Dividend in Respect of the Financial Period Ending 31 December 2023, Payable on 15 March 2024	08/02
BioPharma Credit PLC Declares Ordinary Interim Dividend in Respect of the Financial Period Ending 31 December 2023, Payable on 15 March 2024	08/02
Jefferies cuts BioPharma Credit to 'hold'	07/02
Barratt takes over Redrow in GBP2.5 billion deal	07/02
BioPharma Credit to receive partial prepayment of loan	06/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BioPharma Credit PLC

Azioni

BPCP

GB00BDGKMY29

Altre lingue

Filtri